跳至主要内容
临床试验/NCT05583045
NCT05583045Enrolling By Invitation不适用

PREVENT - Prediabetes Intervention With Olive Leaf Tea

Instituto Politécnico de Bragança2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2022年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
140
试验地点
2
主要终点
HbA1c

研究概览

简要总结

The goal of this interventional study is investigating the effect of the daily consumption of olive leaves tea on glycemic control of individuals diagnosed with pre-diabetes. The hypothesis of this study is that the integration of olive leaf tea on daily food consumption will favors glycemic control and ameliorate insulin resistance in individuals with pre-diabetes.

详细描述

This study is a triple-blinded, randomized, placebo-controlled trial with parallel assignment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The masking is from the responsibility of the tea supplier which was asked to send the tea/placebo codified and only reveal the codification after the end of the trial.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least one of three glycemic criteria for pre diabetes as defined by 2022 American Diabetes Association (ADA) guidelines:
  • Fasting plasma glucose level, 100 to 125 mg per deciliter (5.6 to 6.9 mml per liter);
  • Plasma glucose level 2 hours after a 75-g oral glucose load, 140 to 199 mg per deciliter (7.8 to 11.0 mml per liter);
  • Glycated hemoglobin level, 5.7 to 6.4% (39 to 47 mml per mole).

排除标准

  • Current use of medication for lowering blood cholesterol, glucose or hypertension;
  • History of chronic or severe diseases that may affect study outcomes or limit study participation;
  • Pregnancy and breastfeeding

结局指标

主要结局

HbA1c

时间窗: 12 weeks

Effect of olive leaf tea (OLT) on HbA1c after 12 weeks of intervention in individuals with prediabetes

次要结局

  • Bilirubin(12 weeks)
  • Alkaline Phosphatase(12 weeks)
  • Fasting Plasma Glicose(12 weeks)
  • Insulin(12 weeks)
  • Cholesterol Total, c-HDL, c-LDL and triglycerides(12 weeks)
  • Aspartate transaminase (AST) and Alanine transaminase (ALT)(12 weeks)
  • Creatinine(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Manuela Meireles

Principal Investigator, PhD

Instituto Politécnico de Bragança

研究点 (2)

Loading locations...

相似试验

Prediabetes Intervention With Tea | 临床试验